A shadow hangs over Pride this year. In many states there is grief and fear as LGBTQ people lose crucial rights. So now, more than ever, please be every beautiful thing that you are, without apology. Do not surrender your Pride willingly. Meet the dark with your brightest light.
Checkout our new preprint of a GWAS study of self- and parent-reported obsessive-compulsive symtoms (OCS) in ~34k EUR individuals from 7 population-based (twin-)cohorts. https://t.co/mwf2mRQw5N 1/8
What happens after Cannabis Legalization and why is Québec the way to go? Amazing and informative talks about the https://t.co/3jfyeIjY7n given by @CesarLeosToro and @DavidHammondPhD at #LxAddictions22
Congratulations to Josua Zimmermann (doesn’t care about Twitter) for successfully defending the thesis “Something Involving Serotonin” #PhDone#hecouldnthavedoneitwithoutme
A year ago, a non-academic friend listened to a talk I gave. I thought it went great. My friend disagreed.
She said that academics are experts at making interesting stuff boring—and that we should all take a speech class.
So I did. And here are 6 most useful things I learned.
When your supervisor drops that "women are the better reviewers" just before resubmitting the paper, you know its been a good day. 😁 #scienceisalwaysserious
🚨🚨Yet another paper alert🚨🚨
https://t.co/11UxsOD24v
My First ’shared first authorship’ which was a great experience due to a great team effort by the Center for Forensic Hair Analytics @UZH_en and the Experimental and Clinical Pharmacopsychology lab @PsychZurich
🧵👇
Pre-exposure prophylaxis #PrEP is frequently used to protect against #HIV, however, a new study shows that PrEP is not equally available to all risk groups in #Switzerland.
Read Prof. Jan Fehr's take on the study results and find the link to the study: https://t.co/94k790FXJX